EnzySurge Ltd., a Rosh Ha’Ayin, Israel- and Richmond, VA-based provider of solutions for advanced chronic wound management, successfully expanded its latest $2.5m round of funding to conclude a total of $4.1m.
To date, EnzySurge has raised a total $11m in several private equity rounds led by Eli Gilboa, CPA of Gilboa & Licht, who serves as the company’s active Chairman.
Proceeds will be used to accelerate and broaden EnzySurge’s sales and marketing efforts in the US and the EU during 2010.
The company recently received clearance from FDA to market SilverStream, its ionic silver wound management solution for professional use. FDA also cleared DermaSept, a solution for management of burns, cuts and abrasions.